Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,031 public trials 2,028 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Active, Not Recruiting

A Study to Identify Barriers to Cellular Therapies for People With Plasma Cell Disorders

NCT06126341

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +12 more
Locations
  • Hartford Healthcare Alliance Hartford, Connecticut, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen Montvale, New Jersey, United States
View Trial Details
Active, Not Recruiting

Study of Valemetostat Tosylate as a Single Agent in Patients With Relapse/Refractory B-cell Lymphoma

NCT04842877

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • A.Z. Sint Jan AV Bruges, Belgium
  • University Hospital Gent Ghent, Belgium
  • CH Tourelle Peltzer Verviers, Belgium
  • CHU Mont-Godinne Yvoir, Belgium
View all 22 locations
View Trial Details
Active, Not Recruiting

A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Participants With Relapsed or Refractory Non-Hodgkin Lymphomas (R/R NHL)

NCT03930953

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations
  • Local Institution - 109 Scottsdale, Arizona, United States
  • Local Institution - 111 Jacksonville, Florida, United States
  • Local Institution - 102 Tampa, Florida, United States
  • Local Institution - 108 Overland Park, Kansas, United States
View all 66 locations
View Trial Details
Active, Not Recruiting

A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD22 for Relapsed/Refractory Leukemia or Lymphoma

NCT04571138

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +7 more
Locations
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • Riley Hospital for Children Indianapolis, Indiana, United States
  • Texas Children's Hospital Houston, Texas, United States
  • Seattle Children's Hospital Seattle, Washington, United States
View Trial Details
Active, Not Recruiting

A Study to Evaluate the Safety and Efficacy of Glofitamab in Combination With Rituximab (R) Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Circulating Tumor (ct)DNA High-Risk Patients With Untreated Diffuse Large B-Cell Lymphoma

NCT04980222

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • University of Iowa Iowa City, Iowa, United States
  • Washington University; Wash Uni. Sch. Of Med St Louis, Missouri, United States
View all 18 locations
View Trial Details

Related conditions